In re AndroGel Antitrust Litigation (II), 09-md-2084 (N.D. Ga.)

In the Androgel litigation, Faruqi & Faruqi, LLP represent a pharmaceutical wholesaler and a proposed class of direct purchasers of Abbott’s branded testosterone drug, AndroGel.  The case alleges that Abbott’s predecessor filed baseless patent litigation and entered a series of horizontal market allocation agreements with generic manufacturers Watson and Par/Paddock (also defendants in the case) to delay generic competition in violation of §§ 1 and 2 of the Sherman Act.  The class asserts that, as a result of the delay in generic competition, direct purchasers were overcharged by hundreds of millions of dollars.

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.


Filed on 02/03/2009


1617 JFK Boulevard, Suite 1550

19103 Philadelphia, Pennsylvania

Phone (215) 277-5770

Fax (215) 277-5771


Joseph T. Lukens Phone (215) 277-5770 Fax (215) 277-5771

Peter Kohn Phone (215) 277-5770 Fax (215) 277-5771

Finding us

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331


1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885


3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534


1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania